Skip to main content Skip to secondary navigation


Main content start

Hypophosphatasia is a rare genetic disorder characterized by abnormal bone and teeth development. Our research aims to deepen our understanding of the underlying molecular mechanisms of HPP and develop targeted therapies. By leveraging multiomics data and collaborating with experts in genetics and bone metabolism, we strive to improve diagnostic accuracy, develop novel treatments, and enhance the quality of life for individuals living with HPP.